The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.

about

The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.

Item

http://www.wikidata.org/entity/Q52582484

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.

@en

The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.

@nl

type

Item

label

The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.

@en

The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.

@nl

prefLabel

The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.

@en

The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.

@nl

P1476

The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.

@en

P2093

Corrado Caracò

http://www.w3.org/2001/XMLSchema#string

Igor Puzanov

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Gershenwald

http://www.w3.org/2001/XMLSchema#string

Merrick Ross

http://www.w3.org/2001/XMLSchema#string

Omid Hamid

http://www.w3.org/2001/XMLSchema#string

Ryan J Sullivan

http://www.w3.org/2001/XMLSchema#string

P2860

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program.

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma.

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.

The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.

P2888

s12967-018-1477-8

P304

101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/S12967-018-1477-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Antonio Ascierto

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103405018

http://www.w3.org/2001/XMLSchema#string

P698

29665799

http://www.w3.org/2001/XMLSchema#string

P932

5905181

http://www.w3.org/2001/XMLSchema#string